Ethyl 4-hydroxy-8-nitroquinoline-3-carboxylate

Synonym: 109799-69-1, Ethyl 4-hydroxy-8-nitroquinoline-3-carboxylate, ethyl 8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate, MFCD00968676, ethyl 8-nitro-4-oxo-1H-quinoline-3-carboxylate

CAS No: 109799-69-1

Catalog No:
Brand: Daisa Biopharma
Category: Drug Discovery, Research Area
Tag: 
Molecular Formula: C12H10N2O5Ordor: No order
Storage: Inert atmosphere, dark, 2-8 °C
Molecular Weight: 262.22
Pack Size Available: 1 g, 25 g, 100 g
Place of Origin: India

0 People watching this product now!

cGMP Capacity

kg to MT scale
GMP batches production
Over 20 years of experience

HPAPI production with OEL < 1 μg/m³
Cleanroom Class 100 to Class 100,000
Special type of reactions in cGMP workshop

Cleaning level: Class A B C
cGMP synthesis workshop

Product Description

 Organic building block/reagent.

 

HPLC purity: ≥98% a/a
NMR: Confirm the structure

Physical Form: Solid

Storage temp.: Refrigerator

Shipping Temperature: Room Temperature

Inchi Code: 1S/C12H10N2O5/c1-2-19-12(16)8-6-13-10-7(11(8)15)4-3-5-9(10)14(17)18/h3-6H,2H2,1H3,(H,13,15)

SMILES: O=C(C1=C(O)C2=CC=CC([N+]([O-])=O)=C2N=C1)OCC

734639

About Us

We are a multidisciplinary research organization specializing in Medicinal Chemistry, Process Chemistry, and Biocatalysis—delivering scalable, efficient, and sustainable solutions for complex scientific challenges.

Our medicinal chemistry division drives early-stage drug discovery through the design and synthesis of novel chemical entities, SAR exploration, and creation of natural-product-inspired molecular libraries.

We develop safe, robust, and scalable synthetic routes for APIs and intermediates. Our expertise covers QbD-driven development, impurity profiling, polymorph optimization, and complete CMC/DMF support.

Our biocatalysis services include enzyme screening, whole-cell bioconversion, and industrial bioprocess scale-up—enabling greener, more cost-effective, and sustainable alternatives to traditional chemical transformations.

Our Clients